\-\ Texto\\:\\ \ \(0\)\
\-\ gu\\:\\ left\\ adnexal\\ fullness\\ and\\ tenderness\ \(0\)\
\-\ wbc\\:\\ 17\\.4\ \(0\)\
\-\ afp\\:\\ 1\\.9\\ \\(0\\-10\\.8\\)\ \(0\)\
\-\ ca\\ 125\\:\\ 223\\ \\(\\<35\\)\ \(0\)\
\-\ hcg\\:\\ negative\ \(0\)\
\-\ the\\ patient\\ was\\ initially\\ treated\\ with\\ intravenous\\ antibiotics\\ but\\ her\\ pain\\ became\\ progressively\\ worse\\.\\ \\ clinically\\,\\ she\\ wasn\\'t\\ responding\\ to\\ antibiotic\\ therapy\\ and\\ her\\ ca\\ 125\\ was\\ elevated\\.\\ subsequently\\,\\ a\\ left\\ salpingo\\-oophorectomy\\ was\\ performed\\ with\\ the\\ pathologic\\ diagnosis\\ of\\ tubo\\-ovarian\\ abscess\\ and\\ no\\ evidence\\ of\\ malignancy\\.\ \(0\)\
\-\ us\\ \\(initial\\ \\&\\ follow\\-up\\)\\:\\ 3\\.4\\ x\\ 5\\.7\\ x\\ 4\\.8\\ cm\\ complex\\ l\\ adnexal\\ mass\\ with\\ cystic\\ components\ \(0\)\
\-\ tubo\\-ovarian\\ abscess\ \(4\)\
\-\ \\<li\\>tubo\\-ovarian\\ abscess\\ \\&\\ pid\ \(0\)\
\-\ \\<li\\>endometrioma\ \(0\)\
\-\ \\<li\\>hemorrhagic\\ functional\\ cyst\ \(0\)\
\-\ \\<li\\>benign\\ cystic\\ teratoma\ \(0\)\
\-\ \\<li\\>malignancy\\ \\(many\\ types\\)\ \(0\)\
\-\ \\<li\\>ovarian\\ torsion\ \(0\)\
\-\ \\<li\\>hydrosalpinx\ \(0\)\
\-\ \\<li\\>metastasis\\ to\\ ovary\\ \\(most\\ are\\ solid\\ \\&\\ bilateral\\)\ \(0\)\
\-\ 30\\ year\\-old\\ female\\ with\\ fever\\ and\\ pelvic\\ pain\\.\ \(1\)\
\-\ the\\ differential\\ diagnosis\\ for\\ a\\ complex\\ adnexal\\ mass\\ is\\ long\\ but\\ can\\ be\\ narrowed\\ with\\ clinical\\ information\\ and\\ sonographic\\ characteristics\\.\\ the\\ leading\\ differential\\ diagnoses\\ in\\ this\\ patient\\ were\\ tubo\\-ovarian\\ abscess\\ \\(toa\\)\\ and\\ malignancy\\.\\ \\ the\\ patient\\ was\\ treated\\ operatively\\ because\\ of\\ her\\ failure\\ to\\ respond\\ to\\ conservative\\ therapy\\ and\\ the\\ ca\\-125\\ elevation\\.\\ \\ ca\\-125\\ has\\ been\\ shown\\ to\\ be\\ elevated\\ in\\ many\\ patients\\ with\\ serous\\ epithelial\\ ovarian\\ carcinoma\\ but\\ it\\ can\\ be\\ elevated\\ in\\ other\\ conditions\\ such\\ as\\ pelvic\\ infection\\.\\ \\ typically\\ in\\ these\\ cases\\,\\ the\\ ca\\-125\\ is\\ less\\ than\\ 200\\ miu\\/ml\\.\ \(0\)\
\-\ the\\ sonographic\\ appearance\\ of\\ a\\ toa\\ can\\ be\\ variable\\ but\\ usually\\ is\\ a\\ complex\\ adenxal\\ mass\\ or\\ a\\ cystic\\ mass\\ with\\ internal\\ echos\\.\ \(0\)\
\-\ toas\\ are\\ a\\ known\\ sequela\\ of\\ pid\\ but\\ gonococcus\\ or\\ chlamydia\\ are\\ not\\ typical\\ organisms\\ cultured\\ from\\ toas\\.\\ \\ toas\\ are\\ polymicrobial\\ with\\ a\\ mixture\\ of\\ aerobic\\,\\ anaerobic\\ and\\ facultative\\ organisms\\.\\ \\ cultures\\ from\\ the\\ endocervix\\ are\\ often\\ not\\ accurate\\ representations\\ of\\ the\\ organisms\\ found\\ in\\ toas\\.\\ \\ \ \(0\)\
\-\ treatment\\ of\\ an\\ unruptured\\ toa\\ is\\ conservative\\ with\\ broad\\ spectrum\\ antibiotics\\ with\\ a\\ good\\ response\\ in\\ 60\\-70\\ \\%\\ of\\ patients\\.\\ \\ failure\\ to\\ repsond\\ is\\ defined\\ as\\ increase\\ in\\ abscess\\ size\\,\\ persistent\\ fever\\,\\ persistent\\ leukocytosis\\ or\\ suspected\\ rupture\\ in\\ the\\ first\\ 72\\ hours\\ and\\ these\\ patients\\ are\\ treated\\ operatively\\.\ \(0\)\
\-\ references\\:\\ 1\\)\\ morgan\\,\\ a\\:\\ adenxal\\ mass\\ evaluation\\ in\\ the\\ emergency\\ deptartment\\.\\ emergency\\ medicine\\ clinics\\ of\\ north\\ america\\.\\ vol\\ 19\\:\\ 3\\ august\\ 2001\ \(0\)\
\-\ 2\\)\\ coll\\ o\\,\\ landers\\ d\\:\\ tubo\\-ovarian\\ abscess\\.\\ obstetrics\\ and\\ gynecologic\\ infectious\\ disease\\.\\ raven\\ press\\ ltd\\,\\ new\\ york\\,\\ 1994\\.\ \(0\)\
\-\ for\\ additional\\ information\\,\\ please\\ refer\\ to\\ the\\ factoid\\ linked\\ to\\ this\\ case\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ li\\:\\ 0\\.08075988553304093\ \(0\)\
\-\ toas\\:\\ 0\\.07818641617708647\ \(0\)\
\-\ tubo\\-ovarian\\:\\ 0\\.07337354597151086\ \(0\)\
\-\ \\<\\:\\ 0\\.06581505487254127\ \(0\)\
\-\ \\>\\:\\ 0\\.05036217320919848\ \(0\)\
\-\ ca\\-125\\:\\ 0\\.04941834188146302\ \(0\)\
\-\ toa\\:\\ 0\\.046721234732184765\ \(0\)\
\-\ adenxal\\:\\ 0\\.03601938467142596\ \(0\)\
\-\ abscess\\:\\ 0\\.03594460635211885\ \(0\)\
\-\ organisms\\:\\ 0\\.034443008409579465\ \(0\)\
\-\ adnexal\\:\\ 0\\.03140470418011795\ \(0\)\
\-\ operatively\\:\\ 0\\.030463894788963126\ \(0\)\
\-\ pid\\:\\ 0\\.02934941838860434\ \(0\)\
\-\ 125\\:\\ 0\\.02708411628764651\ \(0\)\
\-\ \\:\\:\\ 0\\.025061525853451554\ \(0\)\
\-\ complex\\:\\ 0\\.02276202357614725\ \(0\)\
\-\ malignancy\\:\\ 0\\.021965119807992345\ \(0\)\
\-\ information\\:\\ 0\\.02065026758583958\ \(0\)\
\-\ but\\:\\ 0\\.020205136375094655\ \(0\)\
\-\ \\&\\:\\ 0\\.019964886200497328\ \(0\)\
\-\ 0\\-10\\.8\\:\\ 0\\.019546604044271616\ \(0\)\
\-\ gonococcus\\:\\ 0\\.019546604044271616\ \(0\)\
\-\ facultative\\:\\ 0\\.019546604044271616\ \(0\)\
\-\ endocervix\\:\\ 0\\.019546604044271616\ \(0\)\
\-\ representations\\:\\ 0\\.019546604044271616\ \(0\)\
\-\ repsond\\:\\ 0\\.019546604044271616\ \(0\)\
\-\ deptartment\\:\\ 0\\.019546604044271616\ \(0\)\
\-\ landers\\:\\ 0\\.019546604044271616\ \(0\)\
\-\ ltd\\:\\ 0\\.019546604044271616\ \(0\)\
\-\ elevated\\:\\ 0\\.019285918146512614\ \(0\)\
\-\ sonographic\\:\\ 0\\.018371129000020362\ \(0\)\
\-\ 17\\.4\\:\\ 0\\.01800969233571298\ \(0\)\
\-\ echos\\:\\ 0\\.01800969233571298\ \(0\)\
\-\ morgan\\:\\ 0\\.01800969233571298\ \(0\)\
\-\ ca\\:\\ 0\\.017646281671906964\ \(0\)\
\-\ ovarian\\:\\ 0\\.017340326587707622\ \(0\)\
\-\ 223\\:\\ 0\\.01711065661928689\ \(0\)\
\-\ her\\:\\ 0\\.01709143010078671\ \(0\)\
\-\ treated\\:\\ 0\\.017014528843129883\ \(0\)\
\-\ coll\\:\\ 0\\.01647278062715434\ \(0\)\
\-\ cystic\\:\\ 0\\.016394452598126996\ \(0\)\
\-\ polymicrobial\\:\\ 0\\.015978005568807976\ \(0\)\
\-\ unruptured\\:\\ 0\\.015978005568807976\ \(0\)\
\-\ obstetrics\\:\\ 0\\.015978005568807976\ \(0\)\
\-\ raven\\:\\ 0\\.015978005568807976\ \(0\)\
\-\ press\\:\\ 0\\.015978005568807976\ \(0\)\
\-\ many\\:\\ 0\\.015575226234622716\ \(0\)\
\-\ salpingo\\-oophorectomy\\:\\ 0\\.015573744910728255\ \(0\)\
\-\ 1994\\.\\:\\ 0\\.015573744910728255\ \(0\)\
\-\ pelvic\\:\\ 0\\.01555321829962436\ \(0\)\
\-\ are\\:\\ 0\\.015497213381768538\ \(0\)\
\-\ aerobic\\:\\ 0\\.015231947394481563\ \(0\)\
\-\ 60\\-70\\:\\ 0\\.015231947394481563\ \(0\)\
\-\ gynecologic\\:\\ 0\\.015231947394481563\ \(0\)\
\-\ conservative\\:\\ 0\\.015134550075805848\ \(0\)\
\-\ persistent\\:\\ 0\\.015114619301580397\ \(0\)\
\-\ 5\\.7\\:\\ 0\\.014935868918595703\ \(0\)\
\-\ chlamydia\\:\\ 0\\.014935868918595703\ \(0\)\
\-\ cultured\\:\\ 0\\.014935868918595703\ \(0\)\
\-\ anaerobic\\:\\ 0\\.014935868918595703\ \(0\)\
\-\ failure\\:\\ 0\\.014844604358453955\ \(0\)\
\-\ patients\\:\\ 0\\.01471113924190261\ \(0\)\
\-\ emergency\\:\\ 0\\.014349395112994571\ \(0\)\
\-\ antibiotics\\:\\ 0\\.014233775422042133\ \(0\)\
\-\ responding\\:\\ 0\\.014036833202169618\ \(0\)\
\-\ 4\\.8\\:\\ 0\\.013859354914645147\ \(0\)\
\-\ clinics\\:\\ 0\\.013859354914645147\ \(0\)\
\-\ sequela\\:\\ 0\\.013542058143823255\ \(0\)\
\-\ mass\\:\\ 0\\.013175842649086082\ \(0\)\
\-\ 200\\:\\ 0\\.013017914511751792\ \(0\)\
\-\ miu\\/ml\\:\\ 0\\.013017914511751792\ \(0\)\
\-\ mixture\\:\\ 0\\.012904182151690704\ \(0\)\
\-\ can\\:\\ 0\\.012892831612876295\ \(0\)\
\-\ fever\\:\\ 0\\.012821563754110714\ \(0\)\
\-\ america\\:\\ 0\\.01279599996949684\ \(0\)\
\-\ 3\\.4\\:\\ 0\\.012692851376071358\ \(0\)\
\-\ vol\\:\\ 0\\.012692851376071358\ \(0\)\
\-\ \\)\\:\\ 0\\.012656987886710512\ \(0\)\
\-\ hydrosalpinx\\:\\ 0\\.012594288709617181\ \(0\)\
\-\ respond\\:\\ 0\\.012594288709617181\ \(0\)\
\-\ serous\\:\\ 0\\.012594288709617181\ \(0\)\
\-\ north\\:\\ 0\\.012594288709617181\ \(0\)\
\-\ x\\:\\ 0\\.012501402817505442\ \(0\)\
\-\ linked\\:\\ 0\\.01249992149361098\ \(0\)\
\-\ gu\\:\\ 0\\.01240940709334434\ \(0\)\
\-\ 1\\.9\\:\\ 0\\.01240940709334434\ \(0\)\
\-\ york\\:\\ 0\\.01240940709334434\ \(0\)\
\-\ accurate\\:\\ 0\\.01232244320608651\ \(0\)\
\-\ refer\\:\\ 0\\.012080316172904709\ \(0\)\
\-\ differential\\:\\ 0\\.012030863988261328\ \(0\)\
\-\ n\\'t\\:\\ 0\\.011932441728340027\ \(0\)\
\-\ be\\:\\ 0\\.011687421049613561\ \(0\)\
\-\ afp\\:\\ 0\\.011663348919017925\ \(0\)\
\-\ endometrioma\\:\\ 0\\.011663348919017925\ \(0\)\
\-\ leukocytosis\\:\\ 0\\.011663348919017925\ \(0\)\
\-\ august\\:\\ 0\\.011663348919017925\ \(0\)\
\-\ epithelial\\:\\ 0\\.011540134171446283\ \(0\)\
\-\ o\\:\\ 0\\.011540134171446283\ \(0\)\
\-\ narrowed\\:\\ 0\\.011423407489660425\ \(0\)\
\-\ diagnoses\\:\\ 0\\.011206914209030899\ \(0\)\
\-\ spectrum\\:\\ 0\\.010963009785052345\ \(0\)\
\-\ was\\:\\ 0\\.010956513550040875\ \(0\)\
\-\ fullness\\:\\ 0\\.010828587120270891\ \(0\)\
\-\ 72\\:\\ 0\\.010743296031960925\ \(0\)\
\-\ hcg\\:\\ 0\\.010661164609166357\ \(0\)\
\-\ torsion\\:\\ 0\\.010581967086767069\ \(0\)\
\-\ functional\\:\\ 0\\.010431584389785337\ \(0\)\
\-\ became\\:\\ 0\\.010223560542296081\ \(0\)\
\-\ ovary\\:\\ 0\\.010223560542296081\ \(0\)\
\-\ progressively\\:\\ 0\\.01019071112813834\ \(0\)\
\-\ therapy\\:\\ 0\\.010131444772685645\ \(0\)\
\-\ variable\\:\\ 0\\.010094985691630117\ \(0\)\
\-\ 2001\\:\\ 0\\.010063974068626259\ \(0\)\
\-\ these\\:\\ 0\\.009861838988726564\ \(0\)\
\-\ broad\\:\\ 0\\.009830358734573429\ \(0\)\
\-\ cultures\\:\\ 0\\.00974873129971153\ \(0\)\
\-\ antibiotic\\:\\ 0\\.009695936069791977\ \(0\)\
\-\ types\\:\\ 0\\.009670002500472261\ \(0\)\
\-\ \\(\\:\\ 0\\.009610133830295261\ \(0\)\
\-\ response\\:\\ 0\\.009496494303355304\ \(0\)\
\-\ d\\:\\ 0\\.009449316036288154\ \(0\)\
\-\ characteristics\\:\\ 0\\.009426098076493708\ \(0\)\
\-\ conditions\\:\\ 0\\.009426098076493708\ \(0\)\
\-\ intravenous\\:\\ 0\\.009403120721647706\ \(0\)\
\-\ elevation\\:\\ 0\\.009357868234660551\ \(0\)\
\-\ components\\:\\ 0\\.009291675411712254\ \(0\)\
\-\ leading\\:\\ 0\\.009064591142470416\ \(0\)\
\-\ medicine\\:\\ 0\\.008987460064675703\ \(0\)\
\-\ teratoma\\:\\ 0\\.008858618311222753\ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.008840808617880704\ \(0\)\
\-\ 19\\:\\ 0\\.008736853881963075\ \(0\)\
\-\ 35\\:\\ 0\\.008719992242527999\ \(0\)\
\-\ diagnosis\\:\\ 0\\.00870163783051184\ \(0\)\
\-\ l\\:\\ 0\\.00863755542824473\ \(0\)\
\-\ subsequently\\:\\ 0\\.008589525501900652\ \(0\)\
\-\ in\\:\\ 0\\.008409257364217947\ \(0\)\
\-\ please\\:\\ 0\\.00840717938607588\ \(0\)\
\-\ worse\\:\\ 0\\.00839263969528617\ \(0\)\
\-\ clinically\\:\\ 0\\.008307348606976201\ \(0\)\
\-\ pathologic\\:\\ 0\\.008293447026014792\ \(0\)\
\-\ suspected\\:\\ 0\\.00815902436123334\ \(0\)\
\-\ infectious\\:\\ 0\\.008146019661782347\ \(0\)\
\-\ good\\:\\ 0\\.008107457039361351\ \(0\)\
\-\ rupture\\:\\ 0\\.008044639951498322\ \(0\)\
\-\ defined\\:\\ 0\\.00798355358394127\ \(0\)\
\-\ us\\:\\ 0\\.007947693585613995\ \(0\)\
\-\ increase\\:\\ 0\\.007947693585613995\ \(0\)\
\-\ a\\:\\ 0\\.007914408462011998\ \(0\)\
\-\ references\\:\\ 0\\.007877667926965882\ \(0\)\
\-\ initially\\:\\ 0\\.007711708080410599\ \(0\)\
\-\ shown\\:\\ 0\\.007597442780820393\ \(0\)\
\-\ typical\\:\\ 0\\.007597442780820393\ \(0\)\
\-\ additional\\:\\ 0\\.007597442780820393\ \(0\)\
\-\ to\\:\\ 0\\.007575487511183792\ \(0\)\
\-\ solid\\:\\ 0\\.0075573096507901985\ \(0\)\
\-\ hours\\:\\ 0\\.007450548356117066\ \(0\)\
\-\ 30\\:\\ 0\\.007286229127394845\ \(0\)\
\-\ metastasis\\:\\ 0\\.00709256613370272\ \(0\)\
\-\ year\\-old\\:\\ 0\\.006959566788687842\ \(0\)\
\-\ wbc\\:\\ 0\\.006907039579990714\ \(0\)\
\-\ typically\\:\\ 0\\.006688305475622998\ \(0\)\
\-\ or\\:\\ 0\\.006662013851199828\ \(0\)\
\-\ factoid\\:\\ 0\\.006641763843933784\ \(0\)\
\-\ because\\:\\ 0\\.006628643717485694\ \(0\)\
\-\ \\,\\:\\ 0\\.006602684524811888\ \(0\)\
\-\ new\\:\\ 0\\.0066026340949014595\ \(0\)\
\-\ benign\\:\\ 0\\.006538914339319737\ \(0\)\
\-\ long\\:\\ 0\\.006532641930892957\ \(0\)\
\-\ less\\:\\ 0\\.006416718413132333\ \(0\)\
\-\ first\\:\\ 0\\.0063580563964209585\ \(0\)\
\-\ internal\\:\\ 0\\.006352274659376433\ \(0\)\
\-\ size\\:\\ 0\\.006352274659376433\ \(0\)\
\-\ cases\\:\\ 0\\.006312219210601181\ \(0\)\
\-\ initial\\:\\ 0\\.006278452645852124\ \(0\)\
\-\ is\\:\\ 0\\.006233822376770794\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.006164161843551535\ \(0\)\
\-\ often\\:\\ 0\\.0060453958947220676\ \(0\)\
\-\ known\\:\\ 0\\.0059956786795206645\ \(0\)\
\-\ found\\:\\ 0\\.0059712319610911585\ \(0\)\
\-\ such\\:\\ 0\\.005923132571709207\ \(0\)\
\-\ clinical\\:\\ 0\\.005829955210789366\ \(0\)\
\-\ tenderness\\:\\ 0\\.0057625550396488544\ \(0\)\
\-\ usually\\:\\ 0\\.005753721183740042\ \(0\)\
\-\ as\\:\\ 0\\.005732051023920744\ \(0\)\
\-\ patient\\:\\ 0\\.005697950759975973\ \(0\)\
\-\ negative\\:\\ 0\\.0056588030185695665\ \(0\)\
\-\ from\\:\\ 0\\.005616122896471008\ \(0\)\
\-\ infection\\:\\ 0\\.005507797281757887\ \(0\)\
\-\ evaluation\\:\\ 0\\.005503855423119308\ \(0\)\
\-\ not\\:\\ 0\\.005475914287103927\ \(0\)\
\-\ appearance\\:\\ 0\\.005418861589212065\ \(0\)\
\-\ carcinoma\\:\\ 0\\.005370127871432076\ \(0\)\
\-\ she\\:\\ 0\\.005318816278168896\ \(0\)\
\-\ performed\\:\\ 0\\.005282878783209133\ \(0\)\
\-\ been\\:\\ 0\\.005154755852470047\ \(0\)\
\-\ cyst\\:\\ 0\\.005091732008927057\ \(0\)\
\-\ cm\\:\\ 0\\.005081942611567596\ \(0\)\
\-\ evidence\\:\\ 0\\.004967721914338975\ \(0\)\
\-\ than\\:\\ 0\\.004964631607357592\ \(0\)\
\-\ pain\\:\\ 0\\.004627974135391285\ \(0\)\
\-\ bilateral\\:\\ 0\\.004598265475198324\ \(0\)\
\-\ 1\\:\\ 0\\.00450848418616343\ \(0\)\
\-\ 3\\:\\ 0\\.0044367528308348995\ \(0\)\
\-\ \\%\\:\\ 0\\.004419780561742811\ \(0\)\
\-\ most\\:\\ 0\\.004374357298731876\ \(0\)\
\-\ other\\:\\ 0\\.004367269509318068\ \(0\)\
\-\ were\\:\\ 0\\.004302186999312464\ \(0\)\
\-\ this\\:\\ 0\\.004262249282989503\ \(0\)\
\-\ it\\:\\ 0\\.004259087327124205\ \(0\)\
\-\ left\\:\\ 0\\.004239934675267914\ \(0\)\
\-\ case\\:\\ 0\\.004145242644938516\ \(0\)\
\-\ 2\\:\\ 0\\.004080054315987907\ \(0\)\
\-\ and\\:\\ 0\\.003991330504040321\ \(0\)\
\-\ the\\:\\ 0\\.003985012641124468\ \(0\)\
\-\ female\\:\\ 0\\.0038952555907934227\ \(0\)\
\-\ treatment\\:\\ 0\\.0038350708638600598\ \(0\)\
\-\ has\\:\\ 0\\.0035580930609629222\ \(0\)\
\-\ for\\:\\ 0\\.003233295559391198\ \(0\)\
\-\ disease\\:\\ 0\\.0030969790270858185\ \(0\)\
\-\ an\\:\\ 0\\.0026200994773497334\ \(0\)\
\-\ with\\:\\ 0\\.0025943276294875775\ \(0\)\
\-\ of\\:\\ 0\\.0025832328336582804\ \(0\)\
\-\ no\\:\\ 0\\.0019078584272811574\ \(0\)\
\-\ \\.\\:\\ 0\\.0014955458666287788\ \(0\)\
